New Cuban Vaccine for Lung Cancer Treatment

The Molecular Immunology Center of Cuba (CIM) has just patented a new therapeutic vaccine for the treatment of lung cancer, said Ana Maria Vazquez, a specialist of that institution.

The expert said that the antigen, called Racotumomab, showed effectiveness in increasing the survival rate of those administered with the drug, as it leads to an increase of tumor apoptosis and decreases the number of tumor vessels.

Racotumomab is the second Cuban therapeutic vaccine for the treatment of this type of cancer, which has a high incidence in Cuba.